What would be more consequential than the Fast Track designation is Priority Review, which shortens the FDA review period from 10 months to 6 months. GTC can ask for Priority Review when the final module of the BLA is submitted in 1Q08.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”